A groundbreaking study from Cedars-Sinai Cancer has revealed a potential game-changer for liver cancer patients. The research, published in Liver Cancer, showcases how a combination of immunotherapy and subsequent surgery can significantly improve survival rates.
But here's where it gets controversial: only a small percentage of patients are currently receiving this life-saving treatment.
Liver cancer is a deadly disease, often detected too late for curative options. When tumors are advanced, immunotherapy can shrink them, but it's not a cure. However, a new study shows that following immunotherapy with a liver transplant or tumor removal can lead to an 85% increase in overall survival rates compared to immunotherapy alone.
Dr. Ju Dong Yang, the study's senior author and medical director of the Liver Cancer Program at Cedars-Sinai, explains, "Our data shows that patients who underwent transplants or tumor removal after immunotherapy lived significantly longer."
The study reviewed data from over 4,300 patients with advanced liver cancer, sourced from the National Cancer Database. Despite the promising results, only about 3% of patients on immunotherapy went on to receive transplants or tumor removal. Most of these patients were treated at academic medical centers like Cedars-Sinai.
"Performing liver transplants after immunotherapy is not yet a common practice," Dr. Yang said. "This is a missed opportunity, as many patients with advanced liver cancer could benefit from this treatment approach."
Dr. Yang plans to continue advocating for this aggressive treatment strategy through a new study, which will enroll patients who receive immunotherapy followed by liver transplants, monitoring their outcomes.
"At Cedars-Sinai Cancer, we believe in patient-centric research that directly improves patient care," said Dr. Robert Figlin, interim director of Cedars-Sinai Cancer. "As an academic medical center, our mission is to advance healthcare for all."
So, why aren't more patients receiving this potentially life-saving treatment? Is it a matter of awareness, accessibility, or something else entirely? What do you think? We'd love to hear your thoughts in the comments!
